vs
Ascendis Pharma A/S（ASND）与FTAI Infrastructure Inc.（FIP）财务数据对比。点击上方公司名可切换其他公司
Ascendis Pharma A/S的季度营收约是FTAI Infrastructure Inc.的1.4倍（$267.3M vs $188.4M），FTAI Infrastructure Inc.同比增速更快（95.9% vs 42.3%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 49.0%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
FTAI基础设施有限公司持有、运营并投资交通物流、中游能源、发电等核心领域的优质关键基础设施资产，主要面向北美市场，聚焦拥有稳定长期现金流、合同约定收入流的项目，为利益相关方创造可持续回报。
ASND vs FIP — 直观对比
营收规模更大
ASND
是对方的1.4倍
$188.4M
营收增速更快
FIP
高出53.6%
42.3%
两年增速更快
ASND
近两年复合增速
49.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $188.4M |
| 净利润 | — | $-150.2M |
| 毛利率 | 90.5% | — |
| 营业利润率 | — | — |
| 净利率 | — | -79.7% |
| 营收同比 | 42.3% | 95.9% |
| 净利润同比 | — | -387.6% |
| 每股收益（稀释后） | — | $-1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDFIP
| Q1 26 | — | $188.4M | ||
| Q4 25 | $267.3M | $143.5M | ||
| Q3 25 | $230.7M | $140.6M | ||
| Q2 25 | $170.7M | $122.3M | ||
| Q1 25 | $109.0M | $96.2M | ||
| Q4 24 | $187.8M | $80.8M | ||
| Q3 24 | $62.5M | $83.3M | ||
| Q2 24 | $38.9M | $84.9M |
净利润ASNDFIP
| Q1 26 | — | $-150.2M | ||
| Q4 25 | — | $-97.7M | ||
| Q3 25 | $-65.9M | $-104.5M | ||
| Q2 25 | $-42.0M | $-70.0M | ||
| Q1 25 | $-102.2M | $120.2M | ||
| Q4 24 | — | $-124.7M | ||
| Q3 24 | $-107.1M | $-43.0M | ||
| Q2 24 | $-118.1M | $-48.1M |
毛利率ASNDFIP
| Q1 26 | — | — | ||
| Q4 25 | 90.5% | — | ||
| Q3 25 | 89.5% | — | ||
| Q2 25 | 80.1% | — | ||
| Q1 25 | 82.6% | — | ||
| Q4 24 | 91.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 68.2% | — |
营业利润率ASNDFIP
| Q1 26 | — | — | ||
| Q4 25 | — | -45.7% | ||
| Q3 25 | 5.1% | -70.8% | ||
| Q2 25 | -33.5% | -56.4% | ||
| Q1 25 | -103.2% | 81.8% | ||
| Q4 24 | — | -152.7% | ||
| Q3 24 | -167.3% | -51.7% | ||
| Q2 24 | -370.2% | -56.4% |
净利率ASNDFIP
| Q1 26 | — | -79.7% | ||
| Q4 25 | — | -68.1% | ||
| Q3 25 | -28.5% | -74.4% | ||
| Q2 25 | -24.6% | -57.2% | ||
| Q1 25 | -93.7% | 125.0% | ||
| Q4 24 | — | -154.4% | ||
| Q3 24 | -171.5% | -51.6% | ||
| Q2 24 | -303.9% | -56.7% |
每股收益（稀释后）ASNDFIP
| Q1 26 | — | $-1.32 | ||
| Q4 25 | — | $-1.04 | ||
| Q3 25 | — | $-1.38 | ||
| Q2 25 | — | $-0.73 | ||
| Q1 25 | — | $0.89 | ||
| Q4 24 | — | $-1.21 | ||
| Q3 24 | — | $-0.45 | ||
| Q2 24 | — | $-0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $37.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-175.8M | $-122.5K |
| 总资产 | $1.4B | $5.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASNDFIP
| Q1 26 | — | $37.9M | ||
| Q4 25 | $665.3M | $57.4M | ||
| Q3 25 | $582.2M | $34.7M | ||
| Q2 25 | $533.6M | $33.6M | ||
| Q1 25 | $559.4M | $26.3M | ||
| Q4 24 | $604.3M | $27.8M | ||
| Q3 24 | $675.6M | $20.3M | ||
| Q2 24 | $279.4M | $33.1M |
总债务ASNDFIP
| Q1 26 | — | — | ||
| Q4 25 | — | $3.8B | ||
| Q3 25 | — | $3.7B | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.6B |
股东权益ASNDFIP
| Q1 26 | — | $-122.5K | ||
| Q4 25 | $-175.8M | $21.3M | ||
| Q3 25 | $-188.0M | $181.1M | ||
| Q2 25 | $-202.6M | $375.5M | ||
| Q1 25 | $-205.0M | $476.2M | ||
| Q4 24 | $-114.2M | $202.7M | ||
| Q3 24 | $-105.1M | $370.8M | ||
| Q2 24 | $-346.8M | $394.8M |
总资产ASNDFIP
| Q1 26 | — | $5.7B | ||
| Q4 25 | $1.4B | $5.7B | ||
| Q3 25 | $1.2B | $5.5B | ||
| Q2 25 | $1.2B | $4.4B | ||
| Q1 25 | $1.1B | $4.1B | ||
| Q4 24 | $1.3B | $2.4B | ||
| Q3 24 | $1.2B | $2.4B | ||
| Q2 24 | $819.0M | $2.5B |
负债/权益比ASNDFIP
| Q1 26 | — | — | ||
| Q4 25 | — | 176.99× | ||
| Q3 25 | — | 20.59× | ||
| Q2 25 | — | 8.21× | ||
| Q1 25 | — | 5.79× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 4.14× | ||
| Q2 24 | — | 3.94× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $-69.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASNDFIP
| Q1 26 | — | $-69.4M | ||
| Q4 25 | $58.2M | $-2.8M | ||
| Q3 25 | — | $-24.4M | ||
| Q2 25 | — | $-5.2M | ||
| Q1 25 | $-15.5M | $-85.7M | ||
| Q4 24 | $-330.7M | $-8.1M | ||
| Q3 24 | — | $14.2M | ||
| Q2 24 | — | $-17.6M |
自由现金流ASNDFIP
| Q1 26 | — | — | ||
| Q4 25 | — | $-68.6M | ||
| Q3 25 | — | $-90.7M | ||
| Q2 25 | — | $-87.5M | ||
| Q1 25 | — | $-151.7M | ||
| Q4 24 | — | $-34.3M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | — | $-32.1M |
自由现金流率ASNDFIP
| Q1 26 | — | — | ||
| Q4 25 | — | -47.8% | ||
| Q3 25 | — | -64.5% | ||
| Q2 25 | — | -71.6% | ||
| Q1 25 | — | -157.7% | ||
| Q4 24 | — | -42.4% | ||
| Q3 24 | — | -14.0% | ||
| Q2 24 | — | -37.9% |
资本支出强度ASNDFIP
| Q1 26 | — | — | ||
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 47.2% | ||
| Q2 25 | — | 67.3% | ||
| Q1 25 | — | 68.6% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 31.1% | ||
| Q2 24 | — | 17.2% |
现金转化率ASNDFIP
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
